DCM
ACAD icon

Driehaus Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Driehaus Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-59,527
Closed -$2.49M – 530
2015
Q2 		$2.49M Buy
59,527
+9,566
+19% +$370K 0.09% 299
2015
Q1 		$1.63M Buy
49,961
+34,761
+229% +$1.19M 0.06% 359
2014
Q4 		$483K Buy
+15,200
New +$431K 0.02% 439
2014
Q3 		– Sell
-159,211
Closed -$3.6M – 523
2014
Q2 		$3.6M Sell
159,211
-144,853
-48% -$3.02M 0.12% 238
2014
Q1 		$7.4M Buy
304,064
+32,285
+12% +$817K 0.25% 122
2013
Q4 		$6.79M Sell
271,779
-50,827
-16% -$1.2M 0.26% 127
2013
Q3 		$8.86M Sell
322,606
-24,279
-7% -$508K 0.36% 94
2013
Q2 		$6.3M Buy
+346,885
New +$4.78M 0.3% 121

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return